Category: Myeloma & Amyloidosis

Key Insights from Attending ASH 2025

Lore Gruenbaum, PhD, Blood Cancer United, Washington, DC

Navigating Complex and Challenging Cases in Myeloma

Angela Dispenzieri, MD, Mayo Clinic, Rochester, MN

CAR-T in 2025: Advancements and the Road Ahead

Jason Westin, M.D., MS, FACP, MD Anderson Cancer Center, Houston, TX

Highlights from Attending ASH 2024

Lee Greenberger, PhD, The Leukemia & Lymphoma Society, Rye Brook, NY

Highlights from Attending the 2024 Society of Hematologic Oncology (SOHO) Annual Meeting

Shira Dinner, MD, Northwestern University, Chicago, IL and Tom Martin, MD, University of California San Francisco, San Francisco, CA

Highlights from attending the 2023 ASH Annual Meeting

Lee Greenberger, PhD, The Leukemia & Lymphoma Society, Rye Brook, NY

Scroll to Top